Clariant AG
CLN.SW · SIX
Market closed7.70-0.050000 (-0.65%)
Key statistics
Previous close7.75
Open7.70
Day high7.76
Day low7.66
52-week high9.06
52-week low6.55
Market cap2.53B
Volume709.45K
Average volume916.92K
P/E ratio-19.42
Forward P/E—
EPS-0.40
Dividend yield+5.45%
Market context
Why it moved
CLN.SW (Clínica Bávaro) experienced a modest decline today amid a lack of company-specific catalysts, with the stock drifting lower in quiet trading as broad market caution and general profit-taking weighed on the share price.
What is happening
Recent company-specific developments and publisher coverage.
ad-hoc-news.de · July 19, 2026Clariant stock trades steady as Q1 2026 results highlight margin resilience and specialty focusReuters · July 17, 2026Clariant rejects Dow Europe's $1.3 billion competition law claimwww.marketscreener.com · July 17, 2026Clariant rejects Dow Europe's $1.3 billion competition law claimClariant · May 8, 2026Clariant delivers resilient performance in challenging environment Mt Newswire · June 4, 2026Clariant Unit Places EUR500 Million Unsecured Eurobonds Mt Newswire · May 13, 2026AlphaValue/Baader Lowers EPS Forecasts for Clariant on Iran War Impact Mt Newswire · May 8, 2026Clariant Books Lower Q1 Sales Mt Newswire · April 7, 2026Berenberg Says No 'Value Catalyst' for Clariant Until Ethylene Litigation Resolution Mt Newswire · February 26, 2026Update: Switzerland's Clariant Swings to FY25 Loss; Sales Down Mt Newswire · February 5, 2026Clariant Expects CHF230 Million Cash Proceeds from Stahl Group Mt Newswire · February 4, 2026Henkel to Buy Specialty Coatings Maker Stahl in EUR2.1 Billion Deal Mt Newswire · December 22, 2025Clariant Denies Competition Law Infringement Allegations